Request for Covid-19 Impact Assessment of this Report
The United States Alirocumab market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Alirocumab market, reaching US$ million by the year 2028. As for the Europe Alirocumab landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Alirocumab players cover AK Scientific, Carbosynth, TargetMol Chemicals, and Beijing Aomi Jiade Pharmaceutical Technology, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Alirocumab market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Patent
Generic
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Biochemical Reagents
Pharmaceutical Intermediates
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
AK Scientific
Carbosynth
TargetMol Chemicals
Beijing Aomi Jiade Pharmaceutical Technology
Hefei Hirisun Pharmatech
Hubei Widely Chemical Technology
Hubei Xingcheng Biotechnology
Hubei Zhongshan Medical Technology
Jiangxi Ruiweier Biotechnology
Kailide Biomedical Technology
Nantong Feiyu Biological Technology
Nantong Hi-Future Biotechnology
Shanghai Baishikai Chemical Technology
Shanghai Biochempartner
Shanghai Loulan Biotechnology
Shanghai Macklin Biochemical
Shanghai Minkai Biotechnology
Shanghai Ruihui Chemical Technology
Shanghai Saimai Biotechnology
Shanghai Yifei Biotechnology
Sichuan Weiqi Biotechnology
Taizhou KEDE Chemical
Taizhou Kerui Bio-Technology
Tianmen Hengchang Chemical
WeiShi Reagent
Wuhan Dingxintong Pharmaceutical
Wuhan Fortuna Chemical
Wuhan Sunrise Technology Development
Wuhan Weisman Bioengineering
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Alirocumab Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Alirocumab by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Alirocumab by Country/Region, 2017, 2022 & 2028
2.2 Alirocumab Segment by Type
2.2.1 Patent
2.2.2 Generic
2.3 Alirocumab Sales by Type
2.3.1 Global Alirocumab Sales Market Share by Type (2017-2022)
2.3.2 Global Alirocumab Revenue and Market Share by Type (2017-2022)
2.3.3 Global Alirocumab Sale Price by Type (2017-2022)
2.4 Alirocumab Segment by Application
2.4.1 Biochemical Reagents
2.4.2 Pharmaceutical Intermediates
2.5 Alirocumab Sales by Application
2.5.1 Global Alirocumab Sale Market Share by Application (2017-2022)
2.5.2 Global Alirocumab Revenue and Market Share by Application (2017-2022)
2.5.3 Global Alirocumab Sale Price by Application (2017-2022)
3 Global Alirocumab by Company
3.1 Global Alirocumab Breakdown Data by Company
3.1.1 Global Alirocumab Annual Sales by Company (2020-2022)
3.1.2 Global Alirocumab Sales Market Share by Company (2020-2022)
3.2 Global Alirocumab Annual Revenue by Company (2020-2022)
3.2.1 Global Alirocumab Revenue by Company (2020-2022)
3.2.2 Global Alirocumab Revenue Market Share by Company (2020-2022)
3.3 Global Alirocumab Sale Price by Company
3.4 Key Manufacturers Alirocumab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Alirocumab Product Location Distribution
3.4.2 Players Alirocumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Alirocumab by Geographic Region
4.1 World Historic Alirocumab Market Size by Geographic Region (2017-2022)
4.1.1 Global Alirocumab Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Alirocumab Annual Revenue by Geographic Region
4.2 World Historic Alirocumab Market Size by Country/Region (2017-2022)
4.2.1 Global Alirocumab Annual Sales by Country/Region (2017-2022)
4.2.2 Global Alirocumab Annual Revenue by Country/Region
4.3 Americas Alirocumab Sales Growth
4.4 APAC Alirocumab Sales Growth
4.5 Europe Alirocumab Sales Growth
4.6 Middle East & Africa Alirocumab Sales Growth
5 Americas
5.1 Americas Alirocumab Sales by Country
5.1.1 Americas Alirocumab Sales by Country (2017-2022)
5.1.2 Americas Alirocumab Revenue by Country (2017-2022)
5.2 Americas Alirocumab Sales by Type
5.3 Americas Alirocumab Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Alirocumab Sales by Region
6.1.1 APAC Alirocumab Sales by Region (2017-2022)
6.1.2 APAC Alirocumab Revenue by Region (2017-2022)
6.2 APAC Alirocumab Sales by Type
6.3 APAC Alirocumab Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Alirocumab by Country
7.1.1 Europe Alirocumab Sales by Country (2017-2022)
7.1.2 Europe Alirocumab Revenue by Country (2017-2022)
7.2 Europe Alirocumab Sales by Type
7.3 Europe Alirocumab Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Alirocumab by Country
8.1.1 Middle East & Africa Alirocumab Sales by Country (2017-2022)
8.1.2 Middle East & Africa Alirocumab Revenue by Country (2017-2022)
8.2 Middle East & Africa Alirocumab Sales by Type
8.3 Middle East & Africa Alirocumab Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Alirocumab
10.3 Manufacturing Process Analysis of Alirocumab
10.4 Industry Chain Structure of Alirocumab
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Alirocumab Distributors
11.3 Alirocumab Customer
12 World Forecast Review for Alirocumab by Geographic Region
12.1 Global Alirocumab Market Size Forecast by Region
12.1.1 Global Alirocumab Forecast by Region (2023-2028)
12.1.2 Global Alirocumab Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Alirocumab Forecast by Type
12.7 Global Alirocumab Forecast by Application
13 Key Players Analysis
13.1 AK Scientific
13.1.1 AK Scientific Company Information
13.1.2 AK Scientific Alirocumab Product Offered
13.1.3 AK Scientific Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 AK Scientific Main Business Overview
13.1.5 AK Scientific Latest Developments
13.2 Carbosynth
13.2.1 Carbosynth Company Information
13.2.2 Carbosynth Alirocumab Product Offered
13.2.3 Carbosynth Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Carbosynth Main Business Overview
13.2.5 Carbosynth Latest Developments
13.3 TargetMol Chemicals
13.3.1 TargetMol Chemicals Company Information
13.3.2 TargetMol Chemicals Alirocumab Product Offered
13.3.3 TargetMol Chemicals Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 TargetMol Chemicals Main Business Overview
13.3.5 TargetMol Chemicals Latest Developments
13.4 Beijing Aomi Jiade Pharmaceutical Technology
13.4.1 Beijing Aomi Jiade Pharmaceutical Technology Company Information
13.4.2 Beijing Aomi Jiade Pharmaceutical Technology Alirocumab Product Offered
13.4.3 Beijing Aomi Jiade Pharmaceutical Technology Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Beijing Aomi Jiade Pharmaceutical Technology Main Business Overview
13.4.5 Beijing Aomi Jiade Pharmaceutical Technology Latest Developments
13.5 Hefei Hirisun Pharmatech
13.5.1 Hefei Hirisun Pharmatech Company Information
13.5.2 Hefei Hirisun Pharmatech Alirocumab Product Offered
13.5.3 Hefei Hirisun Pharmatech Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Hefei Hirisun Pharmatech Main Business Overview
13.5.5 Hefei Hirisun Pharmatech Latest Developments
13.6 Hubei Widely Chemical Technology
13.6.1 Hubei Widely Chemical Technology Company Information
13.6.2 Hubei Widely Chemical Technology Alirocumab Product Offered
13.6.3 Hubei Widely Chemical Technology Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Hubei Widely Chemical Technology Main Business Overview
13.6.5 Hubei Widely Chemical Technology Latest Developments
13.7 Hubei Xingcheng Biotechnology
13.7.1 Hubei Xingcheng Biotechnology Company Information
13.7.2 Hubei Xingcheng Biotechnology Alirocumab Product Offered
13.7.3 Hubei Xingcheng Biotechnology Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Hubei Xingcheng Biotechnology Main Business Overview
13.7.5 Hubei Xingcheng Biotechnology Latest Developments
13.8 Hubei Zhongshan Medical Technology
13.8.1 Hubei Zhongshan Medical Technology Company Information
13.8.2 Hubei Zhongshan Medical Technology Alirocumab Product Offered
13.8.3 Hubei Zhongshan Medical Technology Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Hubei Zhongshan Medical Technology Main Business Overview
13.8.5 Hubei Zhongshan Medical Technology Latest Developments
13.9 Jiangxi Ruiweier Biotechnology
13.9.1 Jiangxi Ruiweier Biotechnology Company Information
13.9.2 Jiangxi Ruiweier Biotechnology Alirocumab Product Offered
13.9.3 Jiangxi Ruiweier Biotechnology Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Jiangxi Ruiweier Biotechnology Main Business Overview
13.9.5 Jiangxi Ruiweier Biotechnology Latest Developments
13.10 Kailide Biomedical Technology
13.10.1 Kailide Biomedical Technology Company Information
13.10.2 Kailide Biomedical Technology Alirocumab Product Offered
13.10.3 Kailide Biomedical Technology Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Kailide Biomedical Technology Main Business Overview
13.10.5 Kailide Biomedical Technology Latest Developments
13.11 Nantong Feiyu Biological Technology
13.11.1 Nantong Feiyu Biological Technology Company Information
13.11.2 Nantong Feiyu Biological Technology Alirocumab Product Offered
13.11.3 Nantong Feiyu Biological Technology Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Nantong Feiyu Biological Technology Main Business Overview
13.11.5 Nantong Feiyu Biological Technology Latest Developments
13.12 Nantong Hi-Future Biotechnology
13.12.1 Nantong Hi-Future Biotechnology Company Information
13.12.2 Nantong Hi-Future Biotechnology Alirocumab Product Offered
13.12.3 Nantong Hi-Future Biotechnology Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Nantong Hi-Future Biotechnology Main Business Overview
13.12.5 Nantong Hi-Future Biotechnology Latest Developments
13.13 Shanghai Baishikai Chemical Technology
13.13.1 Shanghai Baishikai Chemical Technology Company Information
13.13.2 Shanghai Baishikai Chemical Technology Alirocumab Product Offered
13.13.3 Shanghai Baishikai Chemical Technology Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Shanghai Baishikai Chemical Technology Main Business Overview
13.13.5 Shanghai Baishikai Chemical Technology Latest Developments
13.14 Shanghai Biochempartner
13.14.1 Shanghai Biochempartner Company Information
13.14.2 Shanghai Biochempartner Alirocumab Product Offered
13.14.3 Shanghai Biochempartner Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Shanghai Biochempartner Main Business Overview
13.14.5 Shanghai Biochempartner Latest Developments
13.15 Shanghai Loulan Biotechnology
13.15.1 Shanghai Loulan Biotechnology Company Information
13.15.2 Shanghai Loulan Biotechnology Alirocumab Product Offered
13.15.3 Shanghai Loulan Biotechnology Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Shanghai Loulan Biotechnology Main Business Overview
13.15.5 Shanghai Loulan Biotechnology Latest Developments
13.16 Shanghai Macklin Biochemical
13.16.1 Shanghai Macklin Biochemical Company Information
13.16.2 Shanghai Macklin Biochemical Alirocumab Product Offered
13.16.3 Shanghai Macklin Biochemical Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Shanghai Macklin Biochemical Main Business Overview
13.16.5 Shanghai Macklin Biochemical Latest Developments
13.17 Shanghai Minkai Biotechnology
13.17.1 Shanghai Minkai Biotechnology Company Information
13.17.2 Shanghai Minkai Biotechnology Alirocumab Product Offered
13.17.3 Shanghai Minkai Biotechnology Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Shanghai Minkai Biotechnology Main Business Overview
13.17.5 Shanghai Minkai Biotechnology Latest Developments
13.18 Shanghai Ruihui Chemical Technology
13.18.1 Shanghai Ruihui Chemical Technology Company Information
13.18.2 Shanghai Ruihui Chemical Technology Alirocumab Product Offered
13.18.3 Shanghai Ruihui Chemical Technology Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Shanghai Ruihui Chemical Technology Main Business Overview
13.18.5 Shanghai Ruihui Chemical Technology Latest Developments
13.19 Shanghai Saimai Biotechnology
13.19.1 Shanghai Saimai Biotechnology Company Information
13.19.2 Shanghai Saimai Biotechnology Alirocumab Product Offered
13.19.3 Shanghai Saimai Biotechnology Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Shanghai Saimai Biotechnology Main Business Overview
13.19.5 Shanghai Saimai Biotechnology Latest Developments
13.20 Shanghai Yifei Biotechnology
13.20.1 Shanghai Yifei Biotechnology Company Information
13.20.2 Shanghai Yifei Biotechnology Alirocumab Product Offered
13.20.3 Shanghai Yifei Biotechnology Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Shanghai Yifei Biotechnology Main Business Overview
13.20.5 Shanghai Yifei Biotechnology Latest Developments
13.21 Sichuan Weiqi Biotechnology
13.21.1 Sichuan Weiqi Biotechnology Company Information
13.21.2 Sichuan Weiqi Biotechnology Alirocumab Product Offered
13.21.3 Sichuan Weiqi Biotechnology Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 Sichuan Weiqi Biotechnology Main Business Overview
13.21.5 Sichuan Weiqi Biotechnology Latest Developments
13.22 Taizhou KEDE Chemical
13.22.1 Taizhou KEDE Chemical Company Information
13.22.2 Taizhou KEDE Chemical Alirocumab Product Offered
13.22.3 Taizhou KEDE Chemical Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.22.4 Taizhou KEDE Chemical Main Business Overview
13.22.5 Taizhou KEDE Chemical Latest Developments
13.23 Taizhou Kerui Bio-Technology
13.23.1 Taizhou Kerui Bio-Technology Company Information
13.23.2 Taizhou Kerui Bio-Technology Alirocumab Product Offered
13.23.3 Taizhou Kerui Bio-Technology Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.23.4 Taizhou Kerui Bio-Technology Main Business Overview
13.23.5 Taizhou Kerui Bio-Technology Latest Developments
13.24 Tianmen Hengchang Chemical
13.24.1 Tianmen Hengchang Chemical Company Information
13.24.2 Tianmen Hengchang Chemical Alirocumab Product Offered
13.24.3 Tianmen Hengchang Chemical Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.24.4 Tianmen Hengchang Chemical Main Business Overview
13.24.5 Tianmen Hengchang Chemical Latest Developments
13.25 WeiShi Reagent
13.25.1 WeiShi Reagent Company Information
13.25.2 WeiShi Reagent Alirocumab Product Offered
13.25.3 WeiShi Reagent Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.25.4 WeiShi Reagent Main Business Overview
13.25.5 WeiShi Reagent Latest Developments
13.26 Wuhan Dingxintong Pharmaceutical
13.26.1 Wuhan Dingxintong Pharmaceutical Company Information
13.26.2 Wuhan Dingxintong Pharmaceutical Alirocumab Product Offered
13.26.3 Wuhan Dingxintong Pharmaceutical Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.26.4 Wuhan Dingxintong Pharmaceutical Main Business Overview
13.26.5 Wuhan Dingxintong Pharmaceutical Latest Developments
13.27 Wuhan Fortuna Chemical
13.27.1 Wuhan Fortuna Chemical Company Information
13.27.2 Wuhan Fortuna Chemical Alirocumab Product Offered
13.27.3 Wuhan Fortuna Chemical Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.27.4 Wuhan Fortuna Chemical Main Business Overview
13.27.5 Wuhan Fortuna Chemical Latest Developments
13.28 Wuhan Sunrise Technology Development
13.28.1 Wuhan Sunrise Technology Development Company Information
13.28.2 Wuhan Sunrise Technology Development Alirocumab Product Offered
13.28.3 Wuhan Sunrise Technology Development Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.28.4 Wuhan Sunrise Technology Development Main Business Overview
13.28.5 Wuhan Sunrise Technology Development Latest Developments
13.29 Wuhan Weisman Bioengineering
13.29.1 Wuhan Weisman Bioengineering Company Information
13.29.2 Wuhan Weisman Bioengineering Alirocumab Product Offered
13.29.3 Wuhan Weisman Bioengineering Alirocumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.29.4 Wuhan Weisman Bioengineering Main Business Overview
13.29.5 Wuhan Weisman Bioengineering Latest Developments
14 Research Findings and Conclusion
Table 1. Alirocumab Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Alirocumab Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Patent
Table 4. Major Players of Generic
Table 5. Global Alirocumab Sales by Type (2017-2022) & (Kg)
Table 6. Global Alirocumab Sales Market Share by Type (2017-2022)
Table 7. Global Alirocumab Revenue by Type (2017-2022) & ($ million)
Table 8. Global Alirocumab Revenue Market Share by Type (2017-2022)
Table 9. Global Alirocumab Sale Price by Type (2017-2022) & (US$/Kg)
Table 10. Global Alirocumab Sales by Application (2017-2022) & (Kg)
Table 11. Global Alirocumab Sales Market Share by Application (2017-2022)
Table 12. Global Alirocumab Revenue by Application (2017-2022)
Table 13. Global Alirocumab Revenue Market Share by Application (2017-2022)
Table 14. Global Alirocumab Sale Price by Application (2017-2022) & (US$/Kg)
Table 15. Global Alirocumab Sales by Company (2020-2022) & (Kg)
Table 16. Global Alirocumab Sales Market Share by Company (2020-2022)
Table 17. Global Alirocumab Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Alirocumab Revenue Market Share by Company (2020-2022)
Table 19. Global Alirocumab Sale Price by Company (2020-2022) & (US$/Kg)
Table 20. Key Manufacturers Alirocumab Producing Area Distribution and Sales Area
Table 21. Players Alirocumab Products Offered
Table 22. Alirocumab Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Alirocumab Sales by Geographic Region (2017-2022) & (Kg)
Table 26. Global Alirocumab Sales Market Share Geographic Region (2017-2022)
Table 27. Global Alirocumab Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Alirocumab Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Alirocumab Sales by Country/Region (2017-2022) & (Kg)
Table 30. Global Alirocumab Sales Market Share by Country/Region (2017-2022)
Table 31. Global Alirocumab Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Alirocumab Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Alirocumab Sales by Country (2017-2022) & (Kg)
Table 34. Americas Alirocumab Sales Market Share by Country (2017-2022)
Table 35. Americas Alirocumab Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Alirocumab Revenue Market Share by Country (2017-2022)
Table 37. Americas Alirocumab Sales by Type (2017-2022) & (Kg)
Table 38. Americas Alirocumab Sales Market Share by Type (2017-2022)
Table 39. Americas Alirocumab Sales by Application (2017-2022) & (Kg)
Table 40. Americas Alirocumab Sales Market Share by Application (2017-2022)
Table 41. APAC Alirocumab Sales by Region (2017-2022) & (Kg)
Table 42. APAC Alirocumab Sales Market Share by Region (2017-2022)
Table 43. APAC Alirocumab Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Alirocumab Revenue Market Share by Region (2017-2022)
Table 45. APAC Alirocumab Sales by Type (2017-2022) & (Kg)
Table 46. APAC Alirocumab Sales Market Share by Type (2017-2022)
Table 47. APAC Alirocumab Sales by Application (2017-2022) & (Kg)
Table 48. APAC Alirocumab Sales Market Share by Application (2017-2022)
Table 49. Europe Alirocumab Sales by Country (2017-2022) & (Kg)
Table 50. Europe Alirocumab Sales Market Share by Country (2017-2022)
Table 51. Europe Alirocumab Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Alirocumab Revenue Market Share by Country (2017-2022)
Table 53. Europe Alirocumab Sales by Type (2017-2022) & (Kg)
Table 54. Europe Alirocumab Sales Market Share by Type (2017-2022)
Table 55. Europe Alirocumab Sales by Application (2017-2022) & (Kg)
Table 56. Europe Alirocumab Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Alirocumab Sales by Country (2017-2022) & (Kg)
Table 58. Middle East & Africa Alirocumab Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Alirocumab Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Alirocumab Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Alirocumab Sales by Type (2017-2022) & (Kg)
Table 62. Middle East & Africa Alirocumab Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Alirocumab Sales by Application (2017-2022) & (Kg)
Table 64. Middle East & Africa Alirocumab Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Alirocumab
Table 66. Key Market Challenges & Risks of Alirocumab
Table 67. Key Industry Trends of Alirocumab
Table 68. Alirocumab Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Alirocumab Distributors List
Table 71. Alirocumab Customer List
Table 72. Global Alirocumab Sales Forecast by Region (2023-2028) & (Kg)
Table 73. Global Alirocumab Sales Market Forecast by Region
Table 74. Global Alirocumab Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Alirocumab Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Alirocumab Sales Forecast by Country (2023-2028) & (Kg)
Table 77. Americas Alirocumab Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Alirocumab Sales Forecast by Region (2023-2028) & (Kg)
Table 79. APAC Alirocumab Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Alirocumab Sales Forecast by Country (2023-2028) & (Kg)
Table 81. Europe Alirocumab Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Alirocumab Sales Forecast by Country (2023-2028) & (Kg)
Table 83. Middle East & Africa Alirocumab Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Alirocumab Sales Forecast by Type (2023-2028) & (Kg)
Table 85. Global Alirocumab Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Alirocumab Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Alirocumab Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Alirocumab Sales Forecast by Application (2023-2028) & (Kg)
Table 89. Global Alirocumab Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Alirocumab Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Alirocumab Revenue Market Share Forecast by Application (2023-2028)
Table 92. AK Scientific Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors
Table 93. AK Scientific Alirocumab Product Offered
Table 94. AK Scientific Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 95. AK Scientific Main Business
Table 96. AK Scientific Latest Developments
Table 97. Carbosynth Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors
Table 98. Carbosynth Alirocumab Product Offered
Table 99. Carbosynth Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 100. Carbosynth Main Business
Table 101. Carbosynth Latest Developments
Table 102. TargetMol Chemicals Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors
Table 103. TargetMol Chemicals Alirocumab Product Offered
Table 104. TargetMol Chemicals Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 105. TargetMol Chemicals Main Business
Table 106. TargetMol Chemicals Latest Developments
Table 107. Beijing Aomi Jiade Pharmaceutical Technology Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors
Table 108. Beijing Aomi Jiade Pharmaceutical Technology Alirocumab Product Offered
Table 109. Beijing Aomi Jiade Pharmaceutical Technology Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 110. Beijing Aomi Jiade Pharmaceutical Technology Main Business
Table 111. Beijing Aomi Jiade Pharmaceutical Technology Latest Developments
Table 112. Hefei Hirisun Pharmatech Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors
Table 113. Hefei Hirisun Pharmatech Alirocumab Product Offered
Table 114. Hefei Hirisun Pharmatech Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 115. Hefei Hirisun Pharmatech Main Business
Table 116. Hefei Hirisun Pharmatech Latest Developments
Table 117. Hubei Widely Chemical Technology Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors
Table 118. Hubei Widely Chemical Technology Alirocumab Product Offered
Table 119. Hubei Widely Chemical Technology Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 120. Hubei Widely Chemical Technology Main Business
Table 121. Hubei Widely Chemical Technology Latest Developments
Table 122. Hubei Xingcheng Biotechnology Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors
Table 123. Hubei Xingcheng Biotechnology Alirocumab Product Offered
Table 124. Hubei Xingcheng Biotechnology Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 125. Hubei Xingcheng Biotechnology Main Business
Table 126. Hubei Xingcheng Biotechnology Latest Developments
Table 127. Hubei Zhongshan Medical Technology Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors
Table 128. Hubei Zhongshan Medical Technology Alirocumab Product Offered
Table 129. Hubei Zhongshan Medical Technology Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 130. Hubei Zhongshan Medical Technology Main Business
Table 131. Hubei Zhongshan Medical Technology Latest Developments
Table 132. Jiangxi Ruiweier Biotechnology Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors
Table 133. Jiangxi Ruiweier Biotechnology Alirocumab Product Offered
Table 134. Jiangxi Ruiweier Biotechnology Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 135. Jiangxi Ruiweier Biotechnology Main Business
Table 136. Jiangxi Ruiweier Biotechnology Latest Developments
Table 137. Kailide Biomedical Technology Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors
Table 138. Kailide Biomedical Technology Alirocumab Product Offered
Table 139. Kailide Biomedical Technology Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 140. Kailide Biomedical Technology Main Business
Table 141. Kailide Biomedical Technology Latest Developments
Table 142. Nantong Feiyu Biological Technology Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors
Table 143. Nantong Feiyu Biological Technology Alirocumab Product Offered
Table 144. Nantong Feiyu Biological Technology Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 145. Nantong Feiyu Biological Technology Main Business
Table 146. Nantong Feiyu Biological Technology Latest Developments
Table 147. Nantong Hi-Future Biotechnology Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors
Table 148. Nantong Hi-Future Biotechnology Alirocumab Product Offered
Table 149. Nantong Hi-Future Biotechnology Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 150. Nantong Hi-Future Biotechnology Main Business
Table 151. Nantong Hi-Future Biotechnology Latest Developments
Table 152. Shanghai Baishikai Chemical Technology Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors
Table 153. Shanghai Baishikai Chemical Technology Alirocumab Product Offered
Table 154. Shanghai Baishikai Chemical Technology Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 155. Shanghai Baishikai Chemical Technology Main Business
Table 156. Shanghai Baishikai Chemical Technology Latest Developments
Table 157. Shanghai Biochempartner Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors
Table 158. Shanghai Biochempartner Alirocumab Product Offered
Table 159. Shanghai Biochempartner Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 160. Shanghai Biochempartner Main Business
Table 161. Shanghai Biochempartner Latest Developments
Table 162. Shanghai Loulan Biotechnology Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors
Table 163. Shanghai Loulan Biotechnology Alirocumab Product Offered
Table 164. Shanghai Loulan Biotechnology Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 165. Shanghai Loulan Biotechnology Main Business
Table 166. Shanghai Loulan Biotechnology Latest Developments
Table 167. Shanghai Macklin Biochemical Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors
Table 168. Shanghai Macklin Biochemical Alirocumab Product Offered
Table 169. Shanghai Macklin Biochemical Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 170. Shanghai Macklin Biochemical Main Business
Table 171. Shanghai Macklin Biochemical Latest Developments
Table 172. Shanghai Minkai Biotechnology Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors
Table 173. Shanghai Minkai Biotechnology Alirocumab Product Offered
Table 174. Shanghai Minkai Biotechnology Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 175. Shanghai Minkai Biotechnology Main Business
Table 176. Shanghai Minkai Biotechnology Latest Developments
Table 177. Shanghai Ruihui Chemical Technology Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors
Table 178. Shanghai Ruihui Chemical Technology Alirocumab Product Offered
Table 179. Shanghai Ruihui Chemical Technology Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 180. Shanghai Ruihui Chemical Technology Main Business
Table 181. Shanghai Ruihui Chemical Technology Latest Developments
Table 182. Shanghai Saimai Biotechnology Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors
Table 183. Shanghai Saimai Biotechnology Alirocumab Product Offered
Table 184. Shanghai Saimai Biotechnology Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 185. Shanghai Saimai Biotechnology Main Business
Table 186. Shanghai Saimai Biotechnology Latest Developments
Table 187. Shanghai Yifei Biotechnology Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors
Table 188. Shanghai Yifei Biotechnology Alirocumab Product Offered
Table 189. Shanghai Yifei Biotechnology Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 190. Shanghai Yifei Biotechnology Main Business
Table 191. Shanghai Yifei Biotechnology Latest Developments
Table 192. Sichuan Weiqi Biotechnology Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors
Table 193. Sichuan Weiqi Biotechnology Alirocumab Product Offered
Table 194. Sichuan Weiqi Biotechnology Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 195. Sichuan Weiqi Biotechnology Main Business
Table 196. Sichuan Weiqi Biotechnology Latest Developments
Table 197. Taizhou KEDE Chemical Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors
Table 198. Taizhou KEDE Chemical Alirocumab Product Offered
Table 199. Taizhou KEDE Chemical Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 200. Taizhou KEDE Chemical Main Business
Table 201. Taizhou KEDE Chemical Latest Developments
Table 202. Taizhou Kerui Bio-Technology Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors
Table 203. Taizhou Kerui Bio-Technology Alirocumab Product Offered
Table 204. Taizhou Kerui Bio-Technology Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 205. Taizhou Kerui Bio-Technology Main Business
Table 206. Taizhou Kerui Bio-Technology Latest Developments
Table 207. Tianmen Hengchang Chemical Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors
Table 208. Tianmen Hengchang Chemical Alirocumab Product Offered
Table 209. Tianmen Hengchang Chemical Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 210. Tianmen Hengchang Chemical Main Business
Table 211. Tianmen Hengchang Chemical Latest Developments
Table 212. WeiShi Reagent Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors
Table 213. WeiShi Reagent Alirocumab Product Offered
Table 214. WeiShi Reagent Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 215. WeiShi Reagent Main Business
Table 216. WeiShi Reagent Latest Developments
Table 217. Wuhan Dingxintong Pharmaceutical Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors
Table 218. Wuhan Dingxintong Pharmaceutical Alirocumab Product Offered
Table 219. Wuhan Dingxintong Pharmaceutical Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 220. Wuhan Dingxintong Pharmaceutical Main Business
Table 221. Wuhan Dingxintong Pharmaceutical Latest Developments
Table 222. Wuhan Fortuna Chemical Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors
Table 223. Wuhan Fortuna Chemical Alirocumab Product Offered
Table 224. Wuhan Fortuna Chemical Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 225. Wuhan Fortuna Chemical Main Business
Table 226. Wuhan Fortuna Chemical Latest Developments
Table 227. Wuhan Sunrise Technology Development Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors
Table 228. Wuhan Sunrise Technology Development Alirocumab Product Offered
Table 229. Wuhan Sunrise Technology Development Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 230. Wuhan Sunrise Technology Development Main Business
Table 231. Wuhan Sunrise Technology Development Latest Developments
Table 232. Wuhan Weisman Bioengineering Basic Information, Alirocumab Manufacturing Base, Sales Area and Its Competitors
Table 233. Wuhan Weisman Bioengineering Alirocumab Product Offered
Table 234. Wuhan Weisman Bioengineering Alirocumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 235. Wuhan Weisman Bioengineering Main Business
Table 236. Wuhan Weisman Bioengineering Latest Developments
List of Figures
Figure 1. Picture of Alirocumab
Figure 2. Alirocumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Alirocumab Sales Growth Rate 2017-2028 (Kg)
Figure 7. Global Alirocumab Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Alirocumab Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Patent
Figure 10. Product Picture of Generic
Figure 11. Global Alirocumab Sales Market Share by Type in 2021
Figure 12. Global Alirocumab Revenue Market Share by Type (2017-2022)
Figure 13. Alirocumab Consumed in Biochemical Reagents
Figure 14. Global Alirocumab Market: Biochemical Reagents (2017-2022) & (Kg)
Figure 15. Alirocumab Consumed in Pharmaceutical Intermediates
Figure 16. Global Alirocumab Market: Pharmaceutical Intermediates (2017-2022) & (Kg)
Figure 17. Global Alirocumab Sales Market Share by Application (2017-2022)
Figure 18. Global Alirocumab Revenue Market Share by Application in 2021
Figure 19. Alirocumab Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Alirocumab Revenue Market Share by Company in 2021
Figure 21. Global Alirocumab Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Alirocumab Revenue Market Share by Geographic Region in 2021
Figure 23. Global Alirocumab Sales Market Share by Region (2017-2022)
Figure 24. Global Alirocumab Revenue Market Share by Country/Region in 2021
Figure 25. Americas Alirocumab Sales 2017-2022 (Kg)
Figure 26. Americas Alirocumab Revenue 2017-2022 ($ Millions)
Figure 27. APAC Alirocumab Sales 2017-2022 (Kg)
Figure 28. APAC Alirocumab Revenue 2017-2022 ($ Millions)
Figure 29. Europe Alirocumab Sales 2017-2022 (Kg)
Figure 30. Europe Alirocumab Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Alirocumab Sales 2017-2022 (Kg)
Figure 32. Middle East & Africa Alirocumab Revenue 2017-2022 ($ Millions)
Figure 33. Americas Alirocumab Sales Market Share by Country in 2021
Figure 34. Americas Alirocumab Revenue Market Share by Country in 2021
Figure 35. United States Alirocumab Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Alirocumab Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Alirocumab Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Alirocumab Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Alirocumab Sales Market Share by Region in 2021
Figure 40. APAC Alirocumab Revenue Market Share by Regions in 2021
Figure 41. China Alirocumab Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Alirocumab Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Alirocumab Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Alirocumab Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Alirocumab Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Alirocumab Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Alirocumab Sales Market Share by Country in 2021
Figure 48. Europe Alirocumab Revenue Market Share by Country in 2021
Figure 49. Germany Alirocumab Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Alirocumab Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Alirocumab Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Alirocumab Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Alirocumab Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Alirocumab Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Alirocumab Revenue Market Share by Country in 2021
Figure 56. Egypt Alirocumab Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Alirocumab Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Alirocumab Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Alirocumab Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Alirocumab Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Alirocumab in 2021
Figure 62. Manufacturing Process Analysis of Alirocumab
Figure 63. Industry Chain Structure of Alirocumab
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...